ZAP Surgical
Private Company
Total funding raised: $75M
Overview
ZAP Surgical is a private medical device company that has developed the ZAP-X, a next-generation, dedicated cranial stereotactic radiosurgery platform. Its key innovations include self-shielding that eliminates the need for costly radiation bunkers, cobalt-free linear accelerator technology, and a unique gyroscopic delivery system designed for superior dosimetry. The company is in the commercial stage, with systems installed in clinical centers globally, and is exploring new clinical applications like radiomodulation for psychiatric conditions.
Technology Platform
ZAP-X® Gyroscopic Radiosurgery® platform: a self-shielded, cobalt-free, dedicated cranial stereotactic radiosurgery system using a 3 MV linear accelerator and a dual independent gantry for non-coplanar radiation delivery.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
ZAP-X competes primarily with Elekta's Gamma Knife (the historical gold standard for dedicated cranial SRS) and with adapted multi-purpose LINACs from Varian (now part of Siemens Healthineers) and Elekta. Its key differentiators are the elimination of radiation vaults and radioactive sources, which targets the economic and logistical barriers of its competitors.